Skip to main content

Table 3 Predictive factors for occult endometrial carcinoma in patients with endometrioid intraepithelial neoplasia who underwent hysterectomy

From: Prevalence of occult endometrial carcinoma in patients with endometrial intraepithelial neoplasia who underwent hysterectomy

Variables

ECA

N (%)

OR (95% CI)

P value

aOR (95% CI)

P value

Age, y

     

< 50, n = 64

23 (35.9)

Reference

0.289

  

≥ 50, n = 49

13 (26.9)

0.644 (0.285–1.453)

   

BMI (kg/m2)

     

≤ 30, n = 63

15 (23.8)

Reference

0.041

  

> 30, n = 50

21 (42.0)

2.317 (1.034–5.194)

   

< 23, n = 25

7 (28.0)

Reference

0.639

  

≥ 23, n = 88

29 (33.0)

1.264 (0.475–3.367)

   

Parity

     

Multiparous, n = 56

13 (22.8)

Reference

   

Nulliparous, n = 57

23 (41.1)

1.801 (1.017–3.189)

0.037

  

Menopausal status

     

Premenopausal, n = 83

29 (34.9)

Reference

0.242

  

Postmenopausal, n = 33

7 (23.3)

0.567 (0.217–1.478)

   

Diabetes mellitus

     

No, n = 96

30 (31.3)

Reference

0.742

  

Yes, n = 17

6 (35.3)

1.200 (0.406–3.549)

   

Hypertension

     

No, n = 87

26 (29.9)

Reference

0.412

  

Yes, n = 26

10 (38.5)

1.466 (0.588–3.657)

   

Endometrium thickness

     

< 2 cm, n = 36

9 (25.0)

Reference

0.236

  

≥ 2 cm, n = 34

13 (38.2)

1.857 (0.667–5.168)

   

Endometrial biopsy methods

     

FC/hysteroscopy, n = 51

11 (21.6)

Reference

0.036

Reference

0.032

ES, n = 62

25 (40.3)

2.457 (1.063–5.682)

 

2.752 (1.092–6.936)

 

Intraoperative gross lesion

     

No gross lesion, n = 56

10 (17.9)

Reference

 

Reference

 

Gross lesion < 2, n = 38

15 (39.5)

3.867 (1.320-11.327)

0.014

3.381 (1.128–10.132)

0.030

Gross lesion ≥ 2, n = 19

11 (57.9)

5.977 (2.264–16.503)

0.001

6.723 (2.338–19.333)

< 0.001

  1. Abbreviations: aOR, adjusted odds ratio; BMI, body mass index; CI, confidence interval; ECA, endometrium carcinoma; ES, endometrial sampling; FC, fractional curettage; OR, odds ratio; TVS, transvaginal sonography